Irbesartan vs Tremelimumab

## Irbesartan vs Tremelimumab: Overview

This comparison examines the pharmacological differences between **Irbesartan** and **Tremelimumab**.

## Mechanism of Action

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Irbesartan — 11-15 hours; Tremelimumab — N/A.

## Chemical Properties

**Molecular Formula**: Irbesartan — C25H28N6O; Tremelimumab — N/A.

**Molecular Weight**: Irbesartan — 428.5320 g/mol; Tremelimumab — N/A.

**Type**: Irbesartan — Small molecule; Tremelimumab — Antibody.